Natera Wins Preliminary Injunction in Patent Infringement La

Order enjoins NeoGenomics from making, using, selling or promoting its RaDaR molecular residual disease assay in the United States with limited exceptions

...

Related Keywords

California , United States , North Carolina , San Carlos , Texas , Delaware , , Delaware Federal District Court , Clinical Laboratory Improvement Amendments , Invitae Corporation , District Court , Neogenomics Labs Inc , Nasdaq , Natera Inc , Middle District , Neogenomics Labs , Neogenomics Radar , Personalized Cancer Monitoring , Markets ,